Delivery Order SPE2DB22D2007-SPE2DB25FJ0TA

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,418.92, is for the delivery of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,273.18 firm fixed-price contract is for the delivery of Dupixent 300 mg/2 ml syringes. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,837.84, is for the delivery of 4,567,874,487 units of the medication Dupixent 300 mg/2 ml syringe. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. This order is not associated with a set-aside program and is open to full and open...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,837.84, is for the delivery of Dupixent 200 mg/1.14 ml syringes. The contract has an ultimate completion date of December 26, 2024 and is a Firm Fixed Price arrangement. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,273.68 firm fixed-price contract is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $16,414.50 and a completion date of September 10, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this contract to provide the medication to support military treatment facilities and other federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price delivery order with a ceiling value of $16,521.51 and a period of performance through April 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999.00, which serves as a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,298.23, is for the supply of Dupixent 300 mg/2 ml syringes, a prescription medication. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order award valued at $22,831.30 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,192,442 units of the drug Dupixent 200 mg/1.14 ml syringe, with a performance period through May 9, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0TA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $46,400.07, is for the delivery of Dupixent 300 mg/2 ml syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is for open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying the requested pharmaceutical product to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:18 PM